Latest Financial Results

Q1 2015

Quarterly Results

Mar 31, 2015

Stock Information

Symbol

OTCQB: GNSZ

Price

Loading...

Change

Loading...

MKT Cap

Loading...

Volume

Loading...

Company Overview

GenSpera, Inc. is a San Antonio-based biotech company that unlocks conventional thinking to conceive, design, and develop cancer therapies. GenSpera's technology platform combines a powerful, plant-derived cytotoxin (thapsigargin) with a patented prodrug delivery system that provides for targeted release of drug candidates within tumors. GenSpera's lead drug candidate, mipsagargin, was granted Orphan Drug designation by the U.S. Food and Drug Administration (FDA) in 2013 for evaluation in patients with hepatocellular carcinoma (liver cancer).

Click here to view GenSpera's profile on OTCMarkets.com

IR Contact Information

Investor Relations
PCG Advisory Group
Adam Holdsworth
535 Fifth Avenue
24th Floor
New York, NY 10017
T: 646-862-4607
adamh@pcgadvisory.com

Transfer Agent
American Stock Transfer and Trust Company
6201 15th Ave.
Brooklyn, NY 11219
T: (800) 937-5449
www.amstock.com

View All Contacts